Icon To Partner With Us Govt Agency To Test Covid: 19 vaccine candidates
Sept 13 (Reuters) - ICON Public Ltd Co ICLR.O said on Wednesday it is partnering with the U.S. government to execute a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates. (Reporting by Pratik Jain in Bengaluru; Editing by Saumyadeb Chakrabarty) ((Pratik.Jain@thomsonreuters.com;))
Recent news on Icon
See all newsIcon Plc Reports Results For The Quarter Ended September 30: Earnings Summary
Icon jumps after third-quarter profit beat
ICON's Q3 adj EPS and adj EBITDA beat analyst expectations
Icon Plc Expected To Post Earnings Of $2.60 A Share: Earnings Preview
Icon Plc Reports Results For The Quarter Ended June 30: Earnings Summary